Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | TP53 | P04637 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | HTR2C | P28335 | 3/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | HTR2A | P28223 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | MTOR | P42345 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | HTR5A | P47898 | 1/20 | 1.00 |
| ▸ | HTR6 | P50406 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metitepine SCHEMBL7517783 | 1.00 | HTR7 (1.00) | HTR7MAPTTP53CYP3A4SMN1; SMN2 | |
| Metitepine SCHEMBL14359602 | 1.00 | HTR7 (1.00) | HTR7MAPTTP53CYP3A4SMN1; SMN2 | |
| Metitepine SCHEMBL29496251 | 1.00 | HTR7 (1.00) | HTR7MAPTTP53CYP3A4SMN1; SMN2 | |
| Metitepine SCHEMBL8169076 | 0.94 | HTR7 (0.89) | HTR7MAPTTP53CYP3A4SMN1; SMN2 | |
| Metitepine SCHEMBL466985 | 0.92 | MAPT (1.00) | HTR7MAPTTP53CYP3A4SMN1; SMN2 | |
| Metitepine SCHEMBL31360614 | 0.92 | MAPT (1.00) | HTR7MAPTTP53CYP3A4SMN1; SMN2 | |
| Metitepine SCHEMBL15475310 | 0.91 | MAPT (1.00) | HTR7MAPTTP53CYP3A4SMN1; SMN2 | |
| Metitepine SCHEMBL2048660 | 0.91 | MAPT (1.00) | HTR7MAPTTP53CYP3A4SMN1; SMN2 | |
| SCHEMBL8877190 | 0.88 | MAPT (0.79) | HTR7MAPTTP53CYP3A4SMN1; SMN2 | |
| SCHEMBL11876604 | 0.87 | HTR7 (0.77) | HTR7MAPTTP53CYP3A4SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2773 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| EP-4618973-A1 | METHODS OF SWITCHING NEUROPSYCHIATRIC MEDICATIONS USING ULOTARONT | Sumitomo Pharma America, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| EP-4547250-A1 | METHODS AND COMPOSITIONS RELATING TO CONTROLLING PSYCHEDELIC EFFECTS WITH SEROTONIN RECEPTOR MODULATORS | Terran Biosciences Inc. (US) | 2025-05-07 | — | — | EP | claimed |
| US-20250049748-A1 | ANALOGS OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE | TERRAN BIOSCIENCES INC (US) | 2025-02-13 | — | — | US | claimed |
| US-20250032503-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | HOTH THERAPEUTICS, INC. | 2025-01-30 | — | — | US | claimed |
| US-20240245693-A1 | COMPOSITIONS AND METHODS OF TISSUE REGENERATION THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-25 | — | — | US | claimed |
| US-20240197681-A1 | METHODS AND COMPOSITIONS RELATING TO PSYCHEDELICS AND SEROTONIN RECEPTOR MODULATORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-06-20 | — | — | US | claimed |
| US-20240165079-A1 | COMBINATION PRODUCT FOR THE TREATMENT OF NEUROLOGICAL AND/OR PSYCHIATRIC DISORDERS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2024-05-23 | — | — | US | claimed |
| WO-2024107681-A1 | METHODS OF SWITCHING NEUROPSYCHIATRIC MEDICATIONS USING ULOTARONT | SUMITOMO PHARMA AMERICA, INC. (US) | 2024-05-23 | — | — | WO | claimed |
| US-20240115564-A1 | HTR1F ANTAGONISTS FOR IMPROVEMENT OF BETA CELL SURVIVAL AND FUNCTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-04-11 | — | — | US | claimed |
| US-20020127544-A1 | Modulators of US 28 | CHEMOCENTRYX | 2002-09-12 | — | — | US | claimed |
| US-20020086870-A1 | Pharmacological treatment for sleep apnea | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2002-07-04 | — | — | US | claimed |
| WO-2002017900-A2 | MODULATORS OF US28 (CHEMOKINES) FOR TREATING CYTOMEGALOVIRUS INFECTIONS | CHEMOCENTRYX, INC. (US) | 2002-03-07 | — | — | WO | claimed |
| JP-2002504510-A | — | — | 2002-02-12 | — | — | JP | claimed |
| US-6331536-B1 | ADMINISTERING TO PATIENT IN NEED THEREOF EFFECTIVE AMOUNT OF SEROTONIN RECEPTOR ANTAGONIST TO PREVENT OR AMELIORATE SLEEP-RELATED BREATHING DISORDER | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2001-12-18 | — | — | US | claimed |
| EP-1066036-A1 | AGENTS WITH SEROTONIN-RELATED ACTIVITY FOR THE TREATMENT FOR SLEEP APNEA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2001-01-10 | — | — | EP | claimed |
| EP-1011661-A1 | MEDIATION OF CIRCADIAN RHYTHMS | LUMINIS PTY. LIMITED (AU) | 2000-06-28 | — | — | EP | claimed |
| WO-1999043319-A1 | AGENTS WITH SEROTONIN-RELATED ACTIVITY FOR THE TREATMENT FOR SLEEP APNEA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1999-09-02 | — | — | WO | claimed |
| WO-1998042331-A1 | MEDIATION OF CIRCADIAN RHYTHMS | LUMINIS PTY. LIMITED (AU) | 1998-10-01 | — | — | WO | claimed |
| US-4444778-A | ANTISEROTONINE AGENTS | COUGHLIN SHAUN R | 1984-04-24 | — | — | US | claimed |